These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26084461)

  • 1. Reverse Remodeling Achieved by Combination Therapy With High-Dose Beta Blocker and Cardiac Resynchronization.
    Muraoka H; Imamura T; Kinugawa K
    Int Heart J; 2015; 56(4):462-5. PubMed ID: 26084461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management.
    Nabeta T; Inomata T; Iida Y; Ikeda Y; Iwamoto-Ishida M; Ishii S; Naruke T; Mizutani T; Shinagawa H; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Jul; 31(7):1109-16. PubMed ID: 26253941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
    Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Dose β-Blocker Therapy Triggers Additional Reverse Remodeling in Patients With Idiopathic Non-Ischemic Cardiomyopathy.
    Nitta D; Kinugawa K; Imamura T; Kato NP; Komuro I
    Int Heart J; 2016 Dec; 57(6):717-724. PubMed ID: 27818482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular reverse remodeling with infantile dilated cardiomyopathy and pitfalls of carvedilol therapy.
    Tsuda E; Negishi J; Noritake K; Iwasa T; Abe T
    J Cardiol; 2016 Feb; 67(2):147-52. PubMed ID: 26572957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cardiac resynchronization therapy on beat-to-beat T-wave amplitude variability.
    Žižek D; Cvijić M; Tasič J; Jan M; Frljak S; Zupan I
    Europace; 2012 Nov; 14(11):1646-52. PubMed ID: 22423254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of synergistic effects of resynchronization therapy and a β-blocker up-titration strategy based on a predefined patient-management program: the RESTORE study.
    Palmisano P; Ammendola E; D'Onofrio A; Accogli M; Calò L; Ruocco A; Rapacciuolo A; Del Giorno G; Bianchi V; Malacrida M; Valsecchi S; Gronda E
    Clin Cardiol; 2015 Jan; 38(1):2-7. PubMed ID: 25580847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CArdiac resynchronization in combination with beta blocker treatment in advanced chronic heart failure (CARIBE-HF): the results of the CARIBE-HF study.
    Grosu A; Senni M; Iacovoni A; Gori M; Cantù F; Bisetti S; De Santo T; De Luca A; Gavazzi A
    Acta Cardiol; 2011 Oct; 66(5):573-80. PubMed ID: 22032050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carvedilol upon intra- and interventricular synchrony in patients with chronic heart failure.
    Castro PF; Mc-Nab P; Quintana JC; Bittner A; Greig D; Vergara I; Vukasovic JL; Corbalan R; Copaja M; Díaz-Araya G; Chiong M; Troncoso R; Alcaino H; Lavandero S
    Am J Cardiol; 2005 Jul; 96(2):267-9. PubMed ID: 16018855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.
    Armenian SH; Hudson MM; Chen MH; Colan SD; Lindenfeld L; Mills G; Siyahian A; Gelehrter S; Dang H; Hein W; Green DM; Robison LL; Wong FL; Douglas PS; Bhatia S
    BMC Cardiovasc Disord; 2016 Oct; 16(1):187. PubMed ID: 27716152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of long-term benefit of cardiac resynchronization therapy in patients with right bundle branch block.
    Leong DP; Höke U; Delgado V; Auger D; Thijssen J; van Erven L; Bax JJ; Schalij MJ; Marsan NA
    Eur Heart J; 2012 Aug; 33(15):1934-41. PubMed ID: 22270539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superresponse to cardiac resynchronization therapy.
    Steffel J; Ruschitzka F
    Circulation; 2014 Jul; 130(1):87-90. PubMed ID: 24982120
    [No Abstract]   [Full Text] [Related]  

  • 18. Does cardiac resynchronization therapy benefit patients with right bundle branch block: cardiac resynchronization therapy has a role in patients with right bundle branch block.
    Auricchio A; Lumens J; Prinzen FW
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):532-42. PubMed ID: 24951571
    [No Abstract]   [Full Text] [Related]  

  • 19. Left bundle branch block-induced left ventricular remodeling and its potential for reverse remodeling.
    Sze E; Daubert JP
    J Interv Card Electrophysiol; 2018 Aug; 52(3):343-352. PubMed ID: 30019271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology.
    Rickard J; Bassiouny M; Cronin EM; Martin DO; Varma N; Niebauer MJ; Tchou PJ; Tang WH; Wilkoff BL
    Am J Cardiol; 2011 Dec; 108(11):1576-80. PubMed ID: 21890086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.